Mesa Laboratories, Inc. (NASDAQ:MLAB) Short Interest Update

Mesa Laboratories, Inc. (NASDAQ:MLAB) was the recipient of a significant drop in short interest in January. As of January 15th, there was short interest totaling 246,660 shares, a drop of 12.1% from the December 31st total of 280,731 shares. Approximately 4.7% of the company’s stock are sold short. Based on an average daily volume of 110,124 shares, the days-to-cover ratio is presently 2.2 days. Based on an average daily volume of 110,124 shares, the days-to-cover ratio is presently 2.2 days. Approximately 4.7% of the company’s stock are sold short.

Institutional Trading of Mesa Laboratories

A number of institutional investors have recently bought and sold shares of the business. Dynamic Technology Lab Private Ltd bought a new stake in shares of Mesa Laboratories during the 2nd quarter valued at $452,000. Geneva Capital Management LLC lifted its position in Mesa Laboratories by 5.2% during the second quarter. Geneva Capital Management LLC now owns 199,092 shares of the medical instruments supplier’s stock worth $18,758,000 after purchasing an additional 9,780 shares during the period. AlphaQuest LLC grew its stake in Mesa Laboratories by 9,667.7% during the second quarter. AlphaQuest LLC now owns 6,056 shares of the medical instruments supplier’s stock worth $571,000 after buying an additional 5,994 shares in the last quarter. Boston Partners grew its stake in Mesa Laboratories by 16.3% during the second quarter. Boston Partners now owns 5,421 shares of the medical instruments supplier’s stock worth $511,000 after buying an additional 758 shares in the last quarter. Finally, State of Alaska Department of Revenue increased its holdings in Mesa Laboratories by 7.1% in the 2nd quarter. State of Alaska Department of Revenue now owns 3,224 shares of the medical instruments supplier’s stock valued at $303,000 after buying an additional 213 shares during the period. Institutional investors own 90.60% of the company’s stock.

Mesa Laboratories Price Performance

Mesa Laboratories stock opened at $87.53 on Wednesday. The company has a market capitalization of $483.17 million, a price-to-earnings ratio of -273.53 and a beta of 0.89. The company has a current ratio of 2.02, a quick ratio of 1.44 and a debt-to-equity ratio of 0.95. Mesa Laboratories has a 12 month low of $55.45 and a 12 month high of $155.12. The stock’s 50 day moving average is $81.41 and its 200-day moving average is $74.49.

Mesa Laboratories Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Monday, March 16th. Investors of record on Saturday, February 28th will be given a dividend of $0.16 per share. This represents a $0.64 dividend on an annualized basis and a yield of 0.7%. The ex-dividend date of this dividend is Friday, February 27th. Mesa Laboratories’s dividend payout ratio (DPR) is currently -200.00%.

Analyst Upgrades and Downgrades

Several research firms have recently commented on MLAB. Weiss Ratings reissued a “sell (d)” rating on shares of Mesa Laboratories in a report on Thursday, January 22nd. Zacks Research raised shares of Mesa Laboratories from a “strong sell” rating to a “hold” rating in a research report on Friday, January 9th. Wall Street Zen upgraded shares of Mesa Laboratories from a “hold” rating to a “buy” rating in a research note on Saturday, November 8th. Finally, Wells Fargo & Company raised their target price on shares of Mesa Laboratories from $75.00 to $83.00 and gave the company an “equal weight” rating in a research note on Monday, December 15th. Two investment analysts have rated the stock with a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, Mesa Laboratories presently has an average rating of “Reduce” and a consensus target price of $83.00.

About Mesa Laboratories

Mesa Laboratories, Inc (NASDAQ: MLAB) is a global provider of instrumentation products designed for critical process monitoring, testing and calibration. Headquartered in Lakewood, Colorado, the company serves a diverse set of end markets including healthcare, pharmaceutical, food and beverage, energy and industrial sectors. With a focus on precision measurement and validation, Mesa Laboratories helps customers ensure regulatory compliance, product safety and operational efficiency across complex manufacturing and sterilization processes.

The company’s product portfolio encompasses biological and chemical indicators for sterilization process validation, digital data loggers and sensors for environmental monitoring, and optical gas analyzers with sample-conditioning solutions for oil, gas and petrochemical applications.